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Susceptibility to tuberculosis is multifactorial. The 
importance of host genetic factors on the susceptibility 
or resistance to tuberculosis has been emphasized by 
many workers. Host genetic factors such as human 
leucocyte antigens (HLA) and non-HLA genes that are 
associated with the susceptibility to tuberculosis will 
serve as genetic markers to predispose or predetermine 
the development of the disease. Such markers may be 
useful to understand the immune mechanism of sus-
ceptibility or resistance to tuberculosis. Association of 
various HLA and non-HLA genes with susceptibility 
to tuberculosis in various ethnic population has been 
established. HLA studies carried out in the Asian 
region, especially in India, revealed the association of 
HLA -DR2 and -DQ1 antigens with the susceptibility 
to pulmonary TB. Further, studies on DNA typing 
explored the association of DRB1 *1501 and *1502 
(DR2 subtypes) in north Indian and DRB1 *1501, DRB1 
*0601 (DQ1 subtype) and DPB1 *02 (DP2 subtype) in 
south Indian population. Various studies on non-classi-
cal major histocompatibility complex (MHC) genes and 
non-MHC/non-HLA gene polymorphisms such as trans-
porter associated with antigen processing (TAP), tumour 
necrosis factor a and b (TNF a and b), mannose bind-
ing lectin (MBL), vitamin D receptor (VDR) (BsmI, 
ApaI, TaqI and FokI polymorphisms), Interleukin-1 
receptor antagonist (IL-1RA) and natural resistance 
associated macrophage protein-1 (NRAMP-1) genes 
revealed the association of TAP2 gene variant along 
with HLA–DR2 and functional mutant homozygotes 
(FMHs) of MBL with the suceptibility to pulmonary 
TB. The polymorphic BsmI, ApaI, TaqI and FokI gene 
variants of VDR showed differential susceptibility and 
resistance with male and female subjects. These studies 
suggest that multicandidate genes are associated with 
the susceptibility to pulmonary tuberculosis in India. 
Host genetics and susceptibility to disease 
Host genetic factors explain, at least in part why some 
people resist infection more successfully than others. Rare 
gene disruptions cause fatal vulnerability to certain patho-
gens, but more subtle differences are common and arise 
from minor variations in many genes. To predict how 
much our genetic make up determines the different ways 
in which we respond to some infectious agents is a diffi-
cult task. This is especially difficult because of the many 
other contributory factors such as previous health status, 
acquired immunity and variability in the pathogen. 
 Analysis of the genetic basis of susceptibility to major 
infectious diseases is potentially a most complex area. 
Many immunogenetic loci influence susceptibility to seve-
ral infectious pathogens. A genetic basis for interindividual 
variation in susceptibility to human infectious diseases has 
been indicated by twin, adoptee, pedigree and candidate 
gene studies1. 
HLA and non-HLA and disease association 
hypotheses 
Several hypotheses were put forward to explain the mecha-
nisms of major histocompatibility complex MHC and 
non-MHC gene association with the diseases. HLA-A, -B, -C 
(class-I) and -DR, -DQ and -DP (class-II) antigens could 
act directly as disease susceptibility agents. For this, three 
possible mechanisms have been suggested: (a) There could 
be antigenic cross-reactivity or mimicry between infectious 
organisms and a given HLA antigen. This phenomenon is 
termed as ‘molecular mimicry’. Serological cross-reac-
tion between HLA-B27 antigen and the bacterial strains 
Klebsiella and Shigella has been identified2,3. This means 
that common antigenic determinants are shared by HLA-
B27 and the bacteria; (b) HLA antigens could act as recep-
tors for microorganism; and (c) HLA antigens could 
influence particular immune responses, acting as immune 
response (Ir) genes. It has been shown that Ir genes regulate 
the immune response to any antigen or pathogen4. 
Immune response gene effcts 
Genetically controlled differences exist in the magnitude 
of immune responses. The genes, which are responsible 
for this variation, were called as immune response (Ir) 
genes initially, till it became clear that Ir genes were, in 
most cases, one and the same as MHC genes. Several 
HLA-linked examples of diseases are available and this 
provides a attractive mechanism to account for disease 
susceptibility. The three major mechanisms involved in Ir 
gene effects are: 
Determinant selection 
The individual MHC molecule selects the determinant of 
an antigen that is displayed to T-cells restricted by that 
MHC molecule. *For correspondence. (e-mail: psraj21@hotmail.com) 
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Holes in the T-cell repertoire 
Gaps or holes may be created in the exported repertoire 
of T-cells that manifest as a failure to recognize some 
intrinsic antigens. 
T-cell mediated suppression 
Active regulation of potentially reactive cells takes place 
by a population of cells whose function is to suppress an 
immune response5. 
 The MHC genes may be physically close to the 
chromosome region that carries  g ne conferring sus-
ceptibility or resistance to a particular disease. This hypo-
thesis may explain the lack of complete association and 
geographical variation in the association, due to linkage 
disequilibrium. 
 Though classical genetic studies in humans and experi-
mental models have clearly documented the primary con-
tribution of the MHC genes, these genes themselves 
appear to be insufficient in conferring susceptibility or 
resistance to disease and suggest the association of non-
HLA genes.   
Host genetic factors and tuberculosis 
susceptibility/resistance 
Mycobacterium tuberculosis is the causative pathogen for 
tuberculosis. Though environmental and socio-economic 
factors are primarily related, numerous studies have empha-
sized the importance of host resi ance and hereditary 
susceptibility. It is estimated that one-third of the world’s 
population is infected with M. tuberculosis. Among the 
infected only around 10% will ever develop clinical 
disease6. This raises the question ‘What is different about 
those who succumb to tuberculosis?’. In 1926, accidental 
administration of live M. tuberculosis (in place of BCG) 
to babies in Lubeck, Germany left some babies unaffected 
whereas it led to severe disease and death in others7. This 
indicates that the majority f he population have effec-
tive innate resistance to tuberculosis. 
 Twin studies have supported a substantial role for host 
genetics in variable susceptibility to tuberculosis. These 
studies have compared the disease status among identical 
and non-identical twins, with the expectation that disease 
with genetically determined component. These twin studies 
have found higher concordance for tuberculosis among 
monozygotic twins compared to dizygotic twins8,9. 
 The association of host genetic factors (HLA and non-
HLA) with the susceptibility or resistance to tuberculosis 
has been studied using various methods such as case-
control studies, candidate gene approach, family-based, 
genome-wide linkage studies. 
 Identifying HLA and non-HLA genes/gene products 
(antigens) which are associated with susceptibility or 
resistance to tuberculosis will serve to provide HLA genetic 
markers to predict the development or predispose tuber-
culosis. The protective association of HLA types will be 
useful for the development of new epitope-based vaccine. 
Studying the role of these markers in the immune mecha-
nism underlying susceptibility or resistance to tuberculosis 
will be useful to understand the immunopathogenesis of 
the disease. Moreover, these studies may be useful for 
better management and control of the disease. 
 
HLA studies in tuberculosis 
Racial differences in susceptibility to tuberculosis are well 
known. Several studies revealed the association of various 
HLA antigens with the disease susceptibility in different 
ethnic populations10–16. For this type of geographic varia-
tion, possible explanations have been put forward. It seems 
likely that evolutionary selection pressures have given 
rise to frequent polymorphisms in genes involved in 
resisting infectious pathogens and contributed to marked 
allele frequency differences at the same loci. When geo-
graphic variation in pathogen polymorphism is super-
imposed on host genetic heterogeneity, considerable varia-
tion may occur in detectable allelic association. Gene–
environmental interactions are likely to introduce another 
layer of complexity. The genes involved in defense 
against infectious pathogens evolve more rapidly than 
others and excessive polymorphism in the human genome 
may result from selection pressures exerted by infectious 
diseases. Similarly, the causative organism M. tuberculo-
sis also has genetic variation. During evolution, all these 
polymorphic forms might have evolved due to the host–
parasite interaction17. 
 
Studies in non-Asian countries 
A larg  number of HLA association studies have been 
carried out in non-Asian countries. One of the first reports 
of an association between HLA and tuberculosis showed 
an increased frequency of HLA-B8 in Canada10. Other 
studie  showed an increased frequency of HLA-B5, -B15 
and -DR5 in the North American blacks11,12, HLA-A2 
and -B5 in the Egyptian population14 and -B27 in the 
Greek population15. A negative association has been 
reported for -DR6 in American blacks13. 
 
Studies in Asian populations 
Several studies of HLA association with pulmonary tuber-
culosis have been carried out in Chinese16, I donesian18 
and Russian patients19. A significantly increased frequency 
of HLA-DR2 was seen in the major studies which have 
revealed HLA-DR2 association with higher susceptibility 
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to tuberculosis. In a small study of tuberculosis in Vietnam, 
a susceptibility association with the rare HLA-DQB1 
*0503 allele was reported20. Another study carried out  
in Thais revealed the association of HLA-DQB1 *0502  
(ref. 21). 
 Of the numerous Indian studies on HLA association 
with pulmonary tuberculosis, an increased frequency of 
HLA-DR2 and –DQ1 was shown to be associated with 
the susceptibility to pulmonary tuberculosis22–24. Mole-
cular study has revealed that the allele DRB1 *1501 of 
HLA-DR2 was higher compared with DRB1 *1502 in 
north Indian patients25. Studies carried out in south 
Indian patients revealed that, HLA-DRB1 *1501, (refs 
26, 27) HLA-DQB1 *0601 (a subtype of HLA-DQ1) and 
-DPB1 *02 were found to be positively associated with 
susceptibility to pulmonary tuberculosis while a negative 
association (preventive fractions associated with resis-
tance) has also been identified (DRB1 *11(5), DRB1 *10, 
DQB1 *0501 and DRB1 *08). Haplotype analysis also 
supports the DRB1 *1501 -DQB1 *0601 association with 
susceptibility to pulmonary tuberculosis26 (Table 1). 
Though HLA-DR2, DQ1 and their subtypes are signi-
ficantly associated with the susceptibility to tuberculosis, 
hey may not be the sole genetic markers to predispose 
tuberculosis (relative risk is around 2.5). This suggested 
to look for the association of various non-HLA gene 
polymorphic variants. Association of multi-candidate genes 
(HLA and non-HLA) has been suggested for various 
infectious diseases17. 
Non-HLA studies in tuberculosis 
In north Indian pulmonary tuberculosis patients, com-
pared with control subjects, the ‘Transporter’ associated 
with antigen processing gene 2 (TAP2) has been shown 
to be associated with the susceptibility to pulmonary 
tuberculosis along with HLA-DR2 (ref. 28). Definite 
association between tuberculosis and the haptoglobin 2–2 
phenotype has been shown in Russian patients29. No such 
association is observed in Indonesians30 and Indians31. 
 Genome-wide linkage studies on sib-pairs of families 
affected with tuberculosis enable the identificatio  of 
several candidate genes that are associated with the sus-
ceptibility to tuberculosis32. Some of the non-HLA candi-
date genes are discussed below.
Table 1. Association of important candidate gene variants of HLA and non-HLA genes with the susceptibility 
or resistance to pulmonary tuberculosis in Indian population 
   
   
Candidate genes Effect Reference 
      
HLA   
 HLA-DR2 Susceptibility 22, 23, 24 
 Sub-type   
 – DRB1 *1501, *1502 Susceptibility 25 
 – DRB1 *1501 Susceptibility 26, 27 
 HLA-DQ1 Susceptibility 24, 26 
 – DQB1 *0601 Susceptibility 26 
 HLA-DP   
 – DPB1 *02 Susceptibility 26 
 Haplotype:   
 DRB1 and 1501-DQB1 *0601 Susceptibility 26 
 DRB1 *11(5), 
 DRB1 *10, 
 DQB1 *0501 
Resistance 26 
 
Non-clas ical HLA 
  
 Transporter Associated with Antigen Processing  
 (TAP) gene TAP2 and DR2 
Susceptibility 28 
 
Non-HLA 
  
 Functional Mutant Homozygotes of Mannose  
 Binding Lectin (MBL) gene (codon 52, 54 and 57)
Susceptibility 36 
 – Heterozygotes of MBL codon 57 Resistance to bacteriological relapse 36 
 Vitamin D Receptor (VDR) gene variants 
 (BsmI, ApaI, TaqI and FokI) 
Differential susceptibility and  
resistance in males and females 
45, 46 
 NRMAP1 [(CA)n, 823 C/T,  
 TGTG+/del and D543N G/A] 
No association with susceptibility or 
resistance 
59 
 
Cytokine gene 
  
 TNFa – 238, – 308 No association 60 
 TNFb No association 60 
 
Haplotypes 
  
 HLA-B17-TNFa-238/A 
 HLA-B17-TNFa-308/2  
 HLA-B17-TNFb-2 
Associated with bacteriological relapse 60 
   
   
þ
ý
ü
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Mannose-binding protein 
Mannose-binding protein (MBP), also known as mannose- 
binding lectin (MBL) is an acute phase protein secreted 
by the liver. It binds mannose and N- cetylglucosamine 
terminated glycoproteins and plays an important role in 
host defence against pathogens. Upon binding with 
certain carbohydrate moieties, such as terminal N-acetyl 
glucosamine or mannose, on various pathogens, MBP 
activates complement via specific protease and acts dir-
ectly as an opsonin using the Clq receptor on macro-
phages. Mutations are found at the coding regions of the 
MBP genes, i.e. at codons 52, 54 and 57 that lead to low 
or near absent serum MBP levels in heterozygote and 
homozygotes respectively. Low serum level of MBP is 
associated with a common opsonic defect and is frequent 
in recurrent infections during infancy and possibly infec-
tions in adult life. 
 Several groups have studied MBL genotypes and tuber-
culosis, following a suggestion that MBL deficiency 
might have been maintained evolutionarily by a reduced 
capacity of mycobacteria to invade macrophages in the 
absence of MBL, leading to resistance to tub rculosis33. 
A study carried out in South Africa suggested that MBL-
54 heterozygotes may be associated with protection against 
tuberculous meningitis34 but a larger study in Gambia 
found no genotypic association35. Our study in south 
Indian population revealed an increased genotype frequ-
ency of MBP functional mutant homozygotes (including 
codons 52, 54 and 57) in pulmonary tuberculosis (10.9%) 
compared with control subjects (1.8%). Analysis of asso-
ciation of MBP genes and HLA-DR2 has showed that 
these genes are associated with susceptibility to pulmo-
nary tuberculosis, independent of each other36 (Table 1). 
Recently, a Mexican study of surfactant genes expressing 
collectins that are evolutionarily and functionally related 
to MBL genes has been suggested to influence tuberculo-
sis susceptibility37.  
Vitamin D receptor 
It has long been suspected that vitamin D may be impor-
tant in immunity to M. tuberculosis. Prior to the 
availability of antituberculous drugs, vitamin D was used 
in the treatment of patients with cutaneous tuberculosis 
and was reported to have dramatic effects38. The pre-
valence of both vitamin-D deficiency and tuberculosis is 
high among Asian immigrants in the UK, suggesting that 
vegetarian diet is a risk factor for tuberculosis39. 1,25-
dihydroxyvitamin D3 (1,25(OH)2D3) is an important 
immuno-modulatory hormone which activates monocytes 
and suppresses lymphocyte proliferation, immunoglo-
bulin production and cytokine synthesis40,41. In vitro, 
1,25 (OH)2D3 enhances the ability of human monocytes 
to restrict the growth of M. tuberculosis40,42. The effects 
of vitamin D are exerted by interaction through vitamin 
D receptor (VDR). Various diallelic polymorphisms have 
been identified in the vitamin D receptor gene and these 
polymorphic variants have been shown to be associated 
with the susceptibility or resistance to tuberculosis. 
 In a study carried out in the Gambian (West Africa) 
pulmonary TB patients, the t  genotype of TaqI poly-
morphism of VDR gene was found less frequently in 
cases of pulmonary TB, suggesting that this genotype 
may be associated with resistance to pulmonary TB 
whereas ApaI polymorphism showed no association43. 
The variant ff genotype (homozygote) of FokI polymor-
phism of VDR gene and 25-hydroxylcholecalciferol 
d ficiency have been shown to be strongly associated 
with pulmonary tuberculosis in Gujarati Indians living in
London44. Our preliminary studies in south Indian 
pulmonary TB patients on BsmI, ApaI, TaqI and FokI 
polymorphisms of VDR gene showed an increased 
frequ ncy of the genotypes Bb (heterozygote) of BsmI, 
TT (homozygote) of TaqI and FF (homozygote) of FokI 
polymorphism, in males and tt genotype (homozygote) of 
TaqI polymorphism in female patients suggesting the 
association with the susceptibility to TB45,46. Whereas 
genotypes BB (homozygotes) of BsmI and AA (homo-
zygous) of ApaI polymorphism are associated with resi-
st nce to pulmonary tuberculosis in male subjects45,46. 
The variant genotypes of BsmI, ApaI, TaqI and FokI sites 
of VDR gene either alone or in combination with each 
other as haplotype may be associated with susceptibility 
or resistance to pulmonary tuberculosis in males or females 
(T ble 1). This type of differential susceptibility with 
variant genotypes of VDR gene in male and female 
s bjects may be due to the circulating level of vitamin 
D3, dietary intake of vitamin D3, level of vitamin D 
receptor expression and other host factors. Further, 
studies on the level of circulating vitamin D3, vitamin D 
receptor expression and the variant genotypes of vitamin 
D receptor will explore the mechanism of tuberculosis 
susceptibility in males and females. It is well established 
that the prevalence of tuberculosis is more in males47. 
Recently, an X chromosome susceptibility gene has been 
suggested which may contribute to the excess of males 
with tuberculosis observed in many populations48. 
 
Natural resi tance associated macrophage  
protein 1 (NRAMP1) 
NRAMP1 (recently renamed as SLC11A1-solute carrier 
family 11, member 1) was identified by several groups 
working on a mouse locus that confers susceptibility to 
intracellular infections, such as Leishmania, Salmonella 
and the BCG strain of Mycobacterium bovis49. NRAMP1, 
like the related NRAMP2 (SLC11A2), is probably a 
divalent cation transporter and is found in the membrane 
of he phagolysosomes50. In mouse models, NRAMP1 is 
important in resistance to several intracellular infections. 
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 The human NRAMP1 gene has several polymor-
phisms51. The effects of NRAMP1 gene variants seem 
more modest, association has been found between tuber-
culosis susceptibility and NRAMP1 in populations as 
diverse as West Africans52,53, Japanese and Koreans54. A 
study carried out in Taiwanese population revealed no 
association of NRAMP1 gene variants with the suscepti-
bility to tuberculosis55. Linkage between tuberculosis and 
the NRAMP1 locus has been shown in a large Canadian 
pedigree56, but linkage was not seen in Brazilian, West 
African or South African populations57,58. 
 Our studies on NRAMP1 gene polymorphism [(CA)n, 
823 C/T, TGTG+/del and D543N G/A] in south Indian 
pulmonary and spinal tuberculosis patients revealed no 
association with the susceptibility to pulmonary and spinal 
TB in Indian population. It was suggested that MHC and 
other non-MHC gene polymorphic variants may be asso-
ciated59 (Table 1). 
Cytokine genes and receptors 
An analysis of the course of infection in gene-k ock-out 
mice has provided examples of the potential relevance of 
polymorphism in cytokine and cytokine receptor genes to 
infectious disease susceptibility in humans. 
 
Tumour necrosis factor-a and b: Increased production of 
inflammatory cytokines, such as tumour necrosis factor-a 
(TNF-a) has been found in tuberculosis and various other 
infectious diseases. TNF-a, is mainly produced by mono-
cytes and macrophages and TNF-b by T-lymphcoytes. 
Variant genotypes of TNF-a are associated with increa-
sed production of TNF-a. Association studies have been 
carried out on polymorphisms in and near the tumour 
necrosis factor (TNF) gene located in class III region of 
MHC. Our studies on TNF-a (– 238 and – 308) and TNF-
b gene polymorphisms in Indian pulmonary tuberculosis 
patients revealed no association either with susceptibility 
or resistance60 (Table 1). A study carried out in Cam-
bodian tuberculosis patients also revealed no association 
with TNF-a61. 
 
Interleukin-1(IL-1): Interleukin-1 (a and b), another in-
flammatory cytokine, gene polymorphism has been studied 
in Gambians62, Gujarati Indians63 and Cambodians61. 
These studies revealed no association with the suscepti-
bility to tuberculosis. 
 
IL-1 receptor antagonist (IL-1RA): Interleukin-1 recep-
tor antagonist (IL-1RA) is another cytokine factor which 
competes for the IL-1 binding site. The association of IL-
1RA gene variants in various diseases has been studied. 
Macrophages from carriers of IL-1RA alleles have ben 
shown to produce more IL-1RA and less IL-1a than other 
genotypes. IL-1RA gene variants are not associated with 
the susceptibility to pulmonary tuberculosis. However, 
association of the haplotype IL-1 Ra A2¯/IL-1b (+ 3953) 
A1+ with the susceptibility has been reported with tuber-
culo s pleurisy63. Our study on IL-1RA gene poly-
morphism in Indian pulmonary tuberculosis patients 
revealed no association with any of the genotypes but 
spinal tuberculosis patients showed a trend towards an 
increased frequency of genotype 22 compared with the 
control subjects45,64. 
 
Interleukin-10: This is a macrophage-deactivating cyto-
kine. NRAMP1 gene has been suggested to influence 
tuberculosis susceptibility by regulation65 of interleukin-
10. In Cambodian patients, association of heterozygosity 
for the -1082 polymorphism of the IL-10 promoter with 
TB susceptibility has been reported61. 
 
Interleukin-12 receptor (IL-12R): Interleukin-12, a cyto-
kine associated with increased production of Th1 type of 
cytokines, binds to interleukin-12 receptor. A case 
control study carried out in Japanese tuberculosis patients 
revealed the association of homozygosity for R214-T365-
R378 allele (genotype 2/2) with the susceptibility to 
tuberculosis. This genetic variation has been suggested to 
predispose individuals to tuberculosis infection by dimini-
shing receptor responsiveness to IL-12 and to IL-23, 
leading to partial dysfunction of interferon-gamma-
mediated immunity66. 
 
Interf ron-g receptor (IFN-gR): Interferon-g receptor 
(IFN- gR)/gene variants has been shown to be associated 
with the susceptibility to atypical mycobacterial infection 
with M. fortuitum, M. cheloni and M. avium67. A different 
mutation, IFN-gR1, was identified in a child with fatal 
disseminated BCG infection68. 
Conclusions 
Developments in modern genetics and genomics have 
contributed to our understanding of the pathogenic pro-
cesses that underlie major infectious diseases by allowing 
a more systematic study of the genetic influences. The 
number of candidate susceptibility genes is expanding 
rapidly. Moreover, genome-wid  linkage analysis is also 
beginning to provide insights into complex disease. Advan-
ces in single nucleotide polymorphism (SNP) typing, 
microarray technology and bioinformatics will be helpful 
in the study of infectious diseases. 
 The development of tuberculosis or other mycobact-
erial diseases is the result of a complex interaction bet-
ween the host and pathogen influenced by environmental 
factors. Numerous host genes are likely to be involved in 
this process. Using a variety of study methods, sub-
stantial progress has already been made in advancing our 
understanding of genetic susceptibility to tuberculosis. 
However, only a small part of the total familiar clustering 
observed in tuberculosis can be explained by the host 
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genes identified to date. There is much work still to be 
done as there are likely to be many more tuberculosis-
susceptibility genes to be identified69. 
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